Provider QP10-21 Commercial Pharmacy Benefit Exclusion for Emtricitabine-Tenofovir Disoproxil Fumarate Tablet 100-150 mg, 133-200 mg, and 167-250 mg Read More
Provider QP12-21 Commercial Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective April 1, 2021 Read More
Provider P11-21 Updated Preadmission Services for Inpatient Stays Reimbursement Policy for Minnesota Health Care Programs Members Read More
Provider P93R1-20 Update: Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements Read More
